Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations
Authors
Keywords
-
Journal
Biomed Research International
Volume 2020, Issue -, Pages 1-27
Publisher
Hindawi Limited
Online
2020-07-04
DOI
10.1155/2020/5120230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Cannabinoid Receptor Activation and BACE-1 Activity Counteracts TgAPP Mice Memory Impairment and Alzheimer’s Disease Lymphoblast Alterations
- (2020) Emilio Nuñez-Borque et al. MOLECULAR NEUROBIOLOGY
- Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer’s Disease
- (2019) Angela De Simone et al. ACS Medicinal Chemistry Letters
- Pharmacological investigation of quinoxaline-bisthiazoles as multitarget-directed ligands for the treatment of Alzheimer’s disease
- (2019) Sneha R. Sagar et al. BIOORGANIC CHEMISTRY
- Design, synthesis, and evaluation of isoflavone analogs as multifunctional agents for the treatment of Alzheimer's disease
- (2019) Dongmei Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease
- (2019) Piyoosh Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
- (2019) Killian Oukoloff et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
- (2019) Dushyant V. Patel et al. ACS Chemical Neuroscience
- Anti‐Alzheimer's multitarget‐directed ligands with serotonin 5‐HT 6 antagonist, butyrylcholinesterase inhibitory, and antioxidant activity
- (2019) Monika Marcinkowska et al. ARCHIV DER PHARMAZIE
- Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer’s disease
- (2019) Anupamjeet Kaur et al. BIOORGANIC CHEMISTRY
- Short amylin receptor antagonist peptides improve memory deficits in Alzheimer’s disease mouse model
- (2019) Rania Soudy et al. Scientific Reports
- A Novel in vivo Anti-amnesic Agent, Specially Designed to Express Both Acetylcholinesterase (AChE) Inhibitory, Serotonergic Subtype 4 Receptor (5-HT4R) Agonist and Serotonergic Subtype 6 Receptor (5-HT6R) Inverse Agonist Activities, With a Potential Interest Against Alzheimer’s Disease
- (2019) Bérénice Hatat et al. Frontiers in Aging Neuroscience
- Multifunctional Mono-Triazole Derivatives Inhibit Aβ42 Aggregation and Cu2+-Mediated Aβ42 Aggregation and Protect Against Aβ42-Induced Cytotoxicity
- (2019) Amandeep Kaur et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease
- (2019) Zhipei Sang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease
- (2019) Mingfei Wu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Neuronal Sigma-1 Receptors: Signaling Functions and Protective Roles in Neurodegenerative Diseases
- (2019) Daniel A. Ryskamp et al. Frontiers in Neuroscience
- Rasagiline derivatives combined with histamine H3 receptor properties
- (2019) K. Lutsenko et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors
- (2019) F. Javier Pérez-Areales et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors
- (2019) Jesús M. Roldán-Peña et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The chemistry toolbox of multitarget-directed ligands for Alzheimer's disease
- (2019) Francesco Mesiti et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
- (2018) Anna Więckowska et al. ACS Chemical Neuroscience
- Thiazolyl-thiadiazines as Beta Site Amyloid Precursor Protein Cleaving Enzyme-1 (BACE-1) Inhibitors and Anti-inflammatory Agents: Multitarget-Directed Ligands for the Efficient Management of Alzheimer’s Disease
- (2018) Sneha R. Sagar et al. ACS Chemical Neuroscience
- N-methyl-D-aspartate receptor–mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease
- (2018) Erin J. Kodis et al. Alzheimers & Dementia
- Substituent effect of N-benzylated gramine derivatives that prevent the PP2A inhibition and dissipate the neuronal Ca 2+ overload, as a multitarget strategy for the treatment of Alzheimer’s disease
- (2018) Dorleta Gonzalez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Investigation of multi-target-directed ligands (MTDLs) with butyrylcholinesterase (BuChE) and indoleamine 2,3-dioxygenase 1 (IDO1) inhibition: The design, synthesis of miconazole analogues targeting Alzheimer’s disease
- (2018) Xin Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure-based design, synthesis, and evaluation of structurally rigid donepezil analogues as dual AChE and BACE-1 inhibitors
- (2018) Moustafa T. Gabr et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Multi-targetable chalcone analogs to treat deadly Alzheimer’s disease: Current view and upcoming advice
- (2018) Xu Zhang et al. BIOORGANIC CHEMISTRY
- Design and synthesis of donepezil analogues as dual AChE and BACE-1 inhibitors
- (2018) Moustafa T. Gabr et al. BIOORGANIC CHEMISTRY
- Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease
- (2018) Aida Iraji et al. BIOORGANIC CHEMISTRY
- Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease
- (2018) Yi-xiang Xu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease
- (2018) Mourad Chioua et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease
- (2018) Zhiren Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Peptides as Potential Therapeutics for Alzheimer’s Disease
- (2018) Samo Ribarič MOLECULES
- Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery
- (2018) Xue-Yang Jiang et al. ACS Medicinal Chemistry Letters
- Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
- (2018) Mohammad H. Baig et al. Frontiers in Aging Neuroscience
- Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
- (2018) Judite R. M. Coimbra et al. Frontiers in Chemistry
- Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer’s Disease
- (2018) Jinhui Hu et al. ACS Chemical Neuroscience
- Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
- (2018) Margherita Brindisi et al. ChemMedChem
- Tubastatin A/ACY-1215 Improves Cognition in Alzheimer's Disease Transgenic Mice
- (2018) Ling Zhang et al. JOURNAL OF ALZHEIMERS DISEASE
- Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase
- (2018) Julien Lalut et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors
- (2018) Cheng-Zhi Gao et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease
- (2018) Jinhui Hu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation
- (2018) Mahnaz Yazdani et al. BIOORGANIC CHEMISTRY
- Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease
- (2017) Aida Iraji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of Glutamate and NMDA Receptors in Alzheimer’s Disease
- (2017) Rui Wang et al. JOURNAL OF ALZHEIMERS DISEASE
- Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease
- (2017) Edilio Borroni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease
- (2017) Veena Theendakara et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- The serotonergic 5-HT4 receptor: A unique modulator of hippocampal synaptic information processing and cognition
- (2017) Hardy Hagena et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Amyotrophic Lateral Sclerosis
- (2017) Robert H. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Memantine and Donepezil Treatment Improves Behavioral and Psychological Symptoms of Dementia-Like Behaviors in Olfactory Bulbectomized Mice
- (2017) Yasushi Yabuki et al. PHARMACOLOGY
- Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease
- (2017) Lhassane Ismaili et al. PROGRESS IN NEUROBIOLOGY
- Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels
- (2017) Sophia Schedin-Weiss et al. Alzheimers Research & Therapy
- Protein misfolding in neurodegenerative diseases: implications and strategies
- (2017) Patrick Sweeney et al. Translational Neurodegeneration
- Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β 1-42 peptide in mice
- (2016) Leandro Cattelan Souza et al. BRAIN BEHAVIOR AND IMMUNITY
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Development of novel cyclic peptides as pro-apoptotic agents
- (2016) Margherita Brindisi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT 4 R) partial agonist and 5-HT 6 R antagonist activities, as potential treatment of Alzheimer’s disease
- (2016) Samir Yahiaoui et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies
- (2016) Margherita Brindisi et al. Future Medicinal Chemistry
- Gramine Derivatives Targeting Ca2+ Channels and Ser/Thr Phosphatases: A New Dual Strategy for the Treatment of Neurodegenerative Diseases
- (2016) Rocío Lajarín-Cuesta et al. JOURNAL OF MEDICINAL CHEMISTRY
- Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer’s Disease Agents
- (2016) Serena Montanari et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease
- (2016) Jack D. Scott et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Update on Poly(ADP-ribose)polymerase-1 (PARP-1) Inhibitors: Opportunities and Challenges in Cancer Therapy
- (2016) Ying-Qing Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
- (2016) Gabriela Mazzanti et al. MOLECULES
- A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer’s Disease Mice
- (2016) Mar Cuadrado-Tejedor et al. NEUROPSYCHOPHARMACOLOGY
- Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition
- (2016) Margherita Brindisi et al. RSC Advances
- One for All? Hitting Multiple Alzheimer's Disease Targets with One Drug
- (2016) Rebecca E. Hughes et al. Frontiers in Neuroscience
- Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
- (2016) Mercedes Unzeta et al. Frontiers in Neuroscience
- Serotonin: A New Hope in Alzheimer’s Disease?
- (2015) Sylvie Claeysen et al. ACS Chemical Neuroscience
- Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core
- (2015) Prasanna Sivaprakasam et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Memantine ER/Donepezil: A Review in Alzheimer’s Disease
- (2015) Sarah L. Greig CNS DRUGS
- Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia
- (2015) Marcin Kołaczkowski et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer’s Disease: The Design of Donecopride
- (2015) Christophe Rochais et al. JOURNAL OF MEDICINAL CHEMISTRY
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- PARP-1 involvement in neurodegeneration: A focus on Alzheimer’s and Parkinson’s diseases
- (2015) Sara Martire et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer’s disease
- (2015) M. Cuadrado-Tejedor et al. Clinical Epigenetics
- Disease-Modifying Anti-Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering withβ-Amyloid Aggregation
- (2014) Simone Brogi et al. CNS Neuroscience & Therapeutics
- Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
- (2014) Ute F. Röhrig et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.
- (2014) M Bond et al. HEALTH TECHNOLOGY ASSESSMENT
- PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition
- (2014) Katja S. Kroker et al. NEUROBIOLOGY OF AGING
- Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
- (2014) C. Lecoutey et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- Acetylation: a new key to unlock tau’s role in neurodegeneration
- (2014) Casey Cook et al. Alzheimers Research & Therapy
- GSK-3β, a pivotal kinase in Alzheimer disease
- (2014) MarÃa Llorens-MarÃtin et al. Frontiers in Molecular Neuroscience
- Untangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease
- (2013) Masha G. Savelieff et al. ACS Chemical Biology
- Calcium channel blockers and dementia
- (2013) V Nimmrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?
- (2013) Michela Rosini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Butyrylcholinesterase and the cholinergic system
- (2013) G.A. Reid et al. NEUROSCIENCE
- Multifunctional Cholinesterase and Amyloid Beta Fibrillization Modulators. Synthesis and Biological Investigation
- (2013) Stefania Butini et al. ACS Medicinal Chemistry Letters
- Alzheimer’s disease: Pathogenesis and prevention
- (2012) Heiko Braak et al. Alzheimers & Dementia
- Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties
- (2012) Stefania Butini et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Roles of Glycogen Synthase Kinase 3 in Alzheimer’s Disease
- (2012) Zhiyou Cai et al. Current Alzheimer Research
- Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer’s disease
- (2012) Paul T Francis et al. Expert Review of Neurotherapeutics
- Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
- (2012) Michael H. Yan et al. FREE RADICAL BIOLOGY AND MEDICINE
- Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation
- (2012) Casey Cook et al. HUMAN MOLECULAR GENETICS
- Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease
- (2012) Fredrik Jeppsson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase-1 (HDAC1) Is a Molecular Switch between Neuronal Survival and Death
- (2012) Farah H. Bardai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of Potent Inhibitors of Human and Mouse Fatty Acid Amide Hydrolases
- (2012) Stefania Butini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mitochondria, oxidative stress and neurodegeneration
- (2012) Antonio Federico et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- An epigenetic blockade of cognitive functions in the neurodegenerating brain
- (2012) Johannes Gräff et al. NATURE
- Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
- (2012) Mark A. Greenough et al. NEUROCHEMISTRY INTERNATIONAL
- The endocannabinoid system: an overview
- (2012) Natalia Battista et al. Frontiers in Behavioral Neuroscience
- Alzheimer's Disease: Redox Dysregulation As a Common Denominator for Diverse Pathogenic Mechanisms
- (2011) Rommy von Bernhardi et al. ANTIOXIDANTS & REDOX SIGNALING
- Cyclic AMP response element-binding protein (CREB) phosphorylation: A mechanistic marker in the development of memory enhancing Alzheimer's disease therapeutics
- (2011) R. Scott Bitner BIOCHEMICAL PHARMACOLOGY
- α-Synuclein misfolding and Parkinson's disease
- (2011) Leonid Breydo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Role of Serotonin in Alzheimerʼs Disease
- (2011) Werner J. Geldenhuys et al. CNS DRUGS
- An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer's disease
- (2011) Kwang-Mook Jung et al. NEUROBIOLOGY OF AGING
- The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents
- (2011) P.H. Hutson et al. NEUROPHARMACOLOGY
- Targeting HDACs: A Promising Therapy for Alzheimer's Disease
- (2011) Ke Xu et al. Oxidative Medicine and Cellular Longevity
- Inflammation and Alzheimer’s disease
- (2010) Young-Jung Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors
- (2010) Jesús Avila et al. Expert Review of Neurotherapeutics
- Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease
- (2010) J. D. Brioni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Indoleamine 2,3-dioxygenase and 3-hydroxykynurenine modifications are found in the neuropathology of Alzheimer's disease
- (2010) David J. Bonda et al. REDOX REPORT
- Inflammation, Cytokines, Immune Response, Apolipoprotein E, Cholesterol, and Oxidative Stress in Alzheimer Disease: Therapeutic Implications
- (2010) Giuseppina Candore et al. REJUVENATION RESEARCH
- Synthesis and SAR of tolylamine 5-HT6 antagonists
- (2009) Jamie M. Singer et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Crystal Structure of the Human Monoacylglycerol Lipase, a Key Actor in Endocannabinoid Signaling
- (2009) Geoffray Labar et al. CHEMBIOCHEM
- HDAC2 negatively regulates memory formation and synaptic plasticity
- (2009) Ji-Song Guan et al. NATURE
- The histamine H3receptor: an attractive target for the treatment of cognitive disorders
- (2008) T A Esbenshade et al. BRITISH JOURNAL OF PHARMACOLOGY
- Amyloid-cholinesterase interactions
- (2008) Nibaldo C. Inestrosa et al. FEBS Journal
- Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
- (2008) Domenico Praticò TRENDS IN PHARMACOLOGICAL SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now